Current Availability and Regulatory Status in the UK Retatrutide is not approved by the MHRA or EMA as of 2025 and cannot be legally prescribed in the UK
Summary: myHMB is Smart Supplementation in the Era of GLP-1 Ultimately, for individuals navigating aggressive weight management protocols, myHMB offers a scientifically-backed approach to muscle preservation
GLP-1 drugs seem to fight addiction by reducing the hormone dopamine in a brain system involved in reward, motivation and stress a system "that is co-opted or hijacked, if you will, by addiction," Al-Aly says
Another small trial found that CBD may reduce drug cravings and anxiety in people recovering from heroin use
Often, obesity contributes to this problem significantly, as excessive body weight can create increased wear and tear on joints and also lead to metabolic syndrome, thereby slowing the healing process and increasing chronic inflammation